User profiles for Rinaldo Pellicano

Pellicano Rinaldo

SC Gastroenterologia e Epatologia, Azienda Ospedaliero-Universitaria Molinette, Torino
Verified email at molinette.piemonte.it
Cited by 10645

Fecal calprotectin: beyond intestinal organic diseases

…, C Rosso, GM Saracco, M Astegiano, R Pellicano - Panminerva …, 2018 - iris.unito.it
Fecal calprotectin (FC) is a calcium-binding protein with antimicrobic, imunomodulatory and
antiproliferative properties that is mainly found in the cytoplasm of neutrophil granulocytes. …

Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures

…, C De Angelis, E Battaglia, A Musso, R Pellicano… - Gastrointestinal …, 2004 - Elsevier
BACKGROUND: Benign, refractory esophageal strictures are an important therapeutic
challenge. Metal stents occasionally have been used, but results have been disappointing. The …

Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes

A Repici, R Pellicano, G Strangio… - Diseases of the colon …, 2009 - journals.lww.com
Open access endoscopy and screening programs enable detection and removal of an
increased number of colon polyps in the early stages of neoplastic transformation. Unfortunately, …

Helicobacter species and liver diseases: association or causation?

R Pellicano, A Ménard, M Rizzetto… - The Lancet Infectious …, 2008 - thelancet.com
The discovery of Helicobacter hepaticus as a causal agent of hepatitis and hepatocarcinoma
in mice has stimulated interest in looking for Helicobacter spp in human liver samples. …

A 2016 panorama of Helicobacter pylori infection: key messages for clinicians.

R Pellicano, DG Ribaldone, S Fagoonee… - Panminerva …, 2016 - europepmc.org
A comment on this article appears in" Which first-line treatment in Piedmont in the year 2017?"
Panminerva Med. 2017 Jun; 59 (2): 197. A comment on this article appears in" Vaccine as …

[HTML][HTML] Infections with Helicobacter pylori and challenges encountered in Africa

S Smith, M Fowora, R Pellicano - World journal of gastroenterology, 2019 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is the causative agent of gastritis, peptic ulcer disease, mucosa
associated lymphoid tissue lymphoma and gastric cancer (GC). While this bacterium infects …

[HTML][HTML] Extra-esophageal presentation of gastroesophageal reflux disease: 2020 update

…, F Barutta, G Beccuti, G Gruden, R Pellicano - Journal of clinical …, 2020 - mdpi.com
Gastroesophageal reflux disease (GERD) is defined by the presence of symptoms induced
by the reflux of the stomach contents into the esophagus. Although clinical manifestations of …

[HTML][HTML] History of inflammatory bowel diseases

GC Actis, R Pellicano, S Fagoonee… - Journal of clinical …, 2019 - mdpi.com
Inflammatory bowel diseases (IBD) are characterized by chronic inflammation of the intestinal
mucosa and unknown etiology. In this review, we identified three main eras in the IBD …

Helicobacters and extragastric diseases

R Pellicano, F Franceschi, G Saracco… - …, 2009 - Wiley Online Library
For two decades, Helicobacter pylori has been considered as the culprit in many extragastric
manifestations. However, for several of these supposed associations the hypothesis of an …

[HTML][HTML] Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma

R Pellicano, V Mazzaferro, WF Grigioni… - World Journal of …, 2004 - ncbi.nlm.nih.gov
AIM: Only a minority of patients carrying a defined viral aetiologic agent develop cirrhosis
and ultimately hepatocellular carcinoma (HCC), the mechanism underlying the worsening is …